Want to see HK:0474 full AI Analyst Report?
Aceso Life Science Group Limited (0474) Financial Statements
Aceso Life Science Group Limited Financial Overview
Aceso Life Science Group Limited's market cap is currently $1.28B. The company's EPS TTM is $0.05; its P/E ratio is 3.04; and it has a dividend yield of 1.20%. Aceso Life Science Group Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 64.00M | $ 195.00M | $ 11.00M | $ 312.00M | $ 315.00M |
| Gross Profit | $ 54.00M | $ 90.00M | $ -100.00M | $ 141.00M | $ 162.00M |
| Operating Income | $ 40.00M | $ -24.00M | $ -224.00M | $ -153.00M | $ 10.00M |
| EBITDA | $ -297.00M | $ -860.00M | $ -630.00M | $ -21.00M | $ -359.00M |
| Net Income | $ 338.00M | $ -895.00M | $ -462.00M | $ -264.00M | $ -370.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 345.00M | $ 207.00M | $ 466.00M | $ 602.00M | $ 717.00M |
| Total Assets | $ 1.79B | $ 3.24B | $ 4.79B | $ 6.30B | $ 6.26B |
| Total Debt | $ 1.19B | $ 2.30B | $ 2.74B | $ 2.34B | $ 3.01B |
| Net Debt | $ 1.04B | $ 2.17B | $ 2.37B | $ 2.16B | $ 2.81B |
| Total Liabilities | $ 1.33B | $ 2.50B | $ 2.97B | $ 3.73B | $ 3.44B |
| Stockholders' Equity | $ 457.00M | $ 12.00M | $ 921.00M | $ 1.55B | $ 2.00B |
| Cash Flow | |||||
| Free Cash Flow | $ 20.00M | $ 15.00M | $ -48.00M | $ 175.00M | $ 259.00M |
| Operating Cash Flow | $ 20.00M | $ 17.00M | $ -37.00M | $ 222.00M | $ 316.00M |
| Investing Cash Flow | $ 674.00M | $ 337.00M | $ 472.00M | $ -120.00M | $ -441.00M |
| Financing Cash Flow | $ -681.00M | $ -587.00M | $ 117.00M | $ -98.00M | $ 126.00M |
Currency in HKD